Quetiapine and the Dopaminergic Epigenetic Control

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Schizophrenia
Interventions
DRUG

Quetiapine fumarate

Dosage and frequency are judged by the study physician. The dosage must not excess 800mg/d.

Trial Locations (1)

91054

Department of Psychiatry and Psychotherapy, University Erlangen-Nuremberg, Erlangen

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

University of Erlangen-Nürnberg Medical School

OTHER